The number of syncytiotrophoblast-derived EVs released from the placenta is significantly increased in GDM patients, and these EVs carry active dipeptidyl peptidase IV (DPPIV) on their surface
By 2050, 1.31 billion people may develop type 2 diabetes worldwide
It binds to and neutralizes free radicals, supports the bodys natural antioxidant processes, and recycles other antioxidants like vitamins C and E
GIP (Glucose-dependent Insulinotropic Polypeptide) receptor agonists , like tirzepatide , take weight management a step further by activating both GLP-1 and GIP receptors
They activate the neurons POMC and NPY/AGRP resulting in increased energy expenditure
Whether you are a provider looking to streamline your prescribing workflow or a practice administrator managing prior authorizations, the information here will save time and improve patient outcomes